AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-5.88 Cr | ₹0.65 Cr | ₹-1.97 Cr | ₹-2.64 Cr | ₹1.95 Cr |
What is the latest Net Cash Inflow / Outflow ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-5.88 Cr |
| Mar2024 | ₹0.65 Cr |
| Mar2023 | ₹-1.97 Cr |
| Mar2022 | ₹-2.64 Cr |
| Mar2021 | ₹1.95 Cr |
How is Net Cash Inflow / Outflow of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-5.88 Cr | Negative | |
| Mar2024 | ₹0.65 Cr | Positive | |
| Mar2023 | ₹-1.97 Cr | Negative | |
| Mar2022 | ₹-2.64 Cr | Negative | |
| Mar2021 | ₹1.95 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹201.0 Cr | -0.6% | -2.6% | -39.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -0.6% |
-2.6% |
-39.4% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses